🔎 Trials Near Me

Hjem › Kreft (alle typer) › Illinois › Chicago

Kliniske studier for Kreft (alle typer) i Chicago, IL

51 studier for Kreft (alle typer) søker deltakere på steder i og rundt Chicago (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)

RekruttererFase 1
  • University of Chicago Medical Center /ID# 278863, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT07409246

uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

RekruttererObservasjonsstudie
  • Northwestern University, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT05874921

A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism

RekruttererFase 3
  • Investigative Site, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT06881992

A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

RekruttererFase 3
  • Northwestern Memorial Hospital, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 24. sep. 2026 · NCT06901531

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

RekruttererFase 3
  • University of Chicago Medical Center /ID# 280149, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT07365241

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

RekruttererFase 2
  • Cancer Treatment Centers of America-Chicago, Chicago
Alder 12 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT02693535

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

RekruttererFase 2/3
  • Northwestern Memorial Hospital, Chicago
  • University Of Chicago Medical Center, Chicago
Alle aldre · Alle kjønn · Oppdatert 18. sep. 2026 · NCT03435796

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

RekruttererFase 2
  • Rush University Medical Center, Chicago
  • University of Chicago Medical Center, Chicago
Alder 18 til 80 · Alle kjønn · Oppdatert 15. sep. 2026 · NCT07002034

Evaluating the Communication Between Patients and Providers in Cancer Clinics

Rekrutterer
  • Northwestern Memorial Hospital, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 15. sep. 2026 · NCT06985953

The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials

Rekrutterer
  • Advocate Illinois Masonic Medical Center, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT06756607

A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001)

RekruttererFase 1
  • Northwestern University ( Site 0101), Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 11. sep. 2026 · NCT07030712

A Phase 1/1b Study of IAM1363 in HER2 Cancers

RekruttererFase 1
  • University of Chicago, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT06253871

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

RekruttererFase 3
  • University of Illinois at Chicago, Chicago
  • University of Chicago Hospital, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 8. sep. 2026 · NCT06119581

Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation

RekruttererFase 3
  • Insight Research Institute, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 3. sep. 2026 · NCT06252649

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

RekruttererObservasjonsstudie
  • Northwestern University Feinberg School of Medicine, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 3. sep. 2026 · NCT06163534

Ovarian Tissue Cryopreservation in Post Pubertal (OTC-Post Pubertal)

RekruttererObservasjonsstudie
  • Ann &Robert H Lurie Children's Hospital, Chicago
Opp til 30 år · Kvinner · Oppdatert 3. sep. 2026 · NCT05309746

Ovarian Tissue Cryopreservation in Pre-Pubertal (OTC-Pre Pubertal)

RekruttererObservasjonsstudie
  • Ann & Robert H Lurie Childrens Hospital, Chicago
Opp til 11 år · Kvinner · Oppdatert 3. sep. 2026 · NCT05299710

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

RekruttererFase 3
  • Northwestern University, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 2. sep. 2026 · NCT06072612

Project: Every Child for Younger Patients With Cancer

RekruttererObservasjonsstudie
  • Lurie Children's Hospital-Chicago, Chicago
  • Northwestern University, Chicago
  • University of Illinois, Chicago
  • og 1 flere
Opp til 25 år · Alle kjønn · Oppdatert 25. aug. 2026 · NCT02402244

Abatacept in Immune Checkpoint Inhibitor Myocarditis

RekruttererFase 3
  • University of Chicago, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 20. aug. 2026 · NCT05335928

Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies

RekruttererFase 1/2
  • Site 05, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 19. aug. 2026 · NCT07276373

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

RekruttererFase 1/2
  • University of Chicago Medical Center, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 19. aug. 2026 · NCT04104776

Tempus Open Link for Individual Voices in Innovative Analytics Registry: Platform Protocol for Multimodal Real-World Evidence in Cancer

RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
  • Tempus AI, Chicago
Alle aldre · Alle kjønn · Oppdatert 10. aug. 2026 · NCT07756034

International Rare Brain Tumor Registry

RekruttererObservasjonsstudie
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Opp til 45 år · Alle kjønn · Oppdatert 7. aug. 2026 · NCT05697874

A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer

RekruttererFase 2
  • Ann & Robert H Lurie Children's Hospital of Chicago, Chicago
Alder 1 til 39 · Alle kjønn · Oppdatert 7. aug. 2026 · NCT05999994

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

RekruttererFase 3
  • John H Stroger Jr Hospital of Cook County, Chicago
  • University of Illinois, Chicago
  • University of Chicago Comprehensive Cancer Center, Chicago
  • og 1 flere
Alder 18 og eldre · Alle kjønn · Oppdatert 7. aug. 2026 · NCT06580314

Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).

RekruttererFase 2
  • Lurie Children's Hospital, Chicago
Alder 1 til 26 · Alle kjønn · Oppdatert 4. aug. 2026 · NCT07680439

Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

RekruttererFase 1/2
  • The University of Chicago Medicine, Chicago
Alder 12 og eldre · Alle kjønn · Oppdatert 14. jul. 2026 · NCT05533697

Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions

Rekrutterer
  • Northwestern University, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 10. jul. 2026 · NCT07556380

Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia

Rekrutterer
  • Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago
Alder 14 og eldre · Alle kjønn · Oppdatert 30. jun. 2026 · NCT03932903

Molecular Genetics Studies of Cancer Patients and Their Relatives

RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
  • John H Stroger Jr Hospital of Cook County, Chicago
  • Rush University Medical Center, Chicago
Alle aldre · Alle kjønn · Oppdatert 29. jun. 2026 · NCT04185935

Advancing Cancer Control Engaged Research Through Transformative Solutions (ACCERT) Social Determinants of Health (SDoH) Navigation Program

RekruttererFrivillige helsepersonell ønskes velkommen
  • Northwestern University, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 25. jun. 2026 · NCT07669753

Childhood Cancer Survivor Study

RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
  • Ana & Robert H. Lurie Children's Hospital of Chicago, Chicago
  • University of Chicago, Chicago
Alle aldre · Alle kjønn · Oppdatert 17. jun. 2026 · NCT01120353

Lactulose to Improve Gut Health in Cancer Patients Receiving Immunotherapy

RekruttererFase 1/2
  • University of Chicago Medicine Comprehensive Cancer Center, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 16. jun. 2026 · NCT07354100

CT-95 in Advanced Cancers Associated With Mesothelin Expression

RekruttererFase 1
  • Context Investigational Site, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 12. jun. 2026 · NCT06756035

Post Mortem Tissue Donation of Pediatric Tumor Tissues and Cells

RekruttererObservasjonsstudie
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Alle aldre · Alle kjønn · Oppdatert 3. jun. 2026 · NCT05120518

My Wellbeing Guide: A Novel Tool for Managing Stress and Improving Quality of Life

Rekrutterer
  • Northwestern University, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 1. jun. 2026 · NCT05369429

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

RekruttererFase 1/2
  • University of Chicago, Chicago
Alder 12 og eldre · Alle kjønn · Oppdatert 27. mai 2026 · NCT03093116

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

RekruttererFase 1/2
  • University of Chicago Medical Center, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 13. mai 2026 · NCT03686124

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

RekruttererFase 2
  • University of Chicago, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 6. mai 2026 · NCT01042379

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

RekruttererFase 1/2
  • Northwestern Memorial Hospital, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 16. apr. 2026 · NCT03328078

Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions

Rekrutterer
  • University of Chicago Medicine, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 4. mar. 2026 · NCT05166694

Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors

RekruttererFase 1/2
  • University of Chicago Medical Center, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 2. mar. 2026 · NCT06014658

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RekruttererObservasjonsstudie
  • Massive Bio SYNERGY-AI site, Chicago
Alle aldre · Alle kjønn · Oppdatert 28. okt. 2025 · NCT03452774

Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.

RekruttererFase 1
  • Northwestern University, Chicago
  • University of Illinois, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2025 · NCT05808634

A Study of NX-1607 in Adults With Advanced Malignancies

RekruttererFase 1
  • University of Chicago, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2025 · NCT05107674

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Rekrutterer
  • Advocate Illinois Masonic Medical Center, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 27. nov. 2024 · NCT03860883

DREAM: Double Lung Transplant REgistry Aimed for Lung-limited Malignancies

RekruttererObservasjonsstudie
  • Thoracic Surgery, Canning Thoracic Institute (Northwestern Memorial Hospital), Chicago
Alder 18 til 75 · Alle kjønn · Oppdatert 14. nov. 2024 · NCT05671887

Kreft (alle typer)-studier i andre byer

Andre studier i Chicago

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.